- Home
- EQX vs TECH Comparison
EQX vs TECH Comparison
Compare EQX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQX
- TECH
- Stock Information
- Founded
- EQX 2007
- TECH 1976
- Country
- EQX Canada
- TECH United States
- Employees
- EQX N/A
- TECH N/A
- Industry
- EQX Precious Metals
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQX Basic Materials
- TECH Health Care
- Exchange
- EQX Nasdaq
- TECH Nasdaq
- Market Cap
- EQX 8.4B
- TECH 9.9B
- IPO Year
- EQX N/A
- TECH 1989
- Fundamental
- Price
- EQX $10.97
- TECH $62.57
- Analyst Decision
- EQX Buy
- TECH Buy
- Analyst Count
- EQX 1
- TECH 13
- Target Price
- EQX $17.00
- TECH $70.58
- AVG Volume (30 Days)
- EQX 13.9M
- TECH 1.8M
- Earning Date
- EQX 11-05-2025
- TECH 11-05-2025
- Dividend Yield
- EQX N/A
- TECH 0.51%
- EPS Growth
- EQX N/A
- TECH N/A
- EPS
- EQX N/A
- TECH 0.46
- Revenue
- EQX $1,905,732,000.00
- TECH $1,219,635,000.00
- Revenue This Year
- EQX $65.90
- TECH $3.72
- Revenue Next Year
- EQX $49.28
- TECH $7.67
- P/E Ratio
- EQX N/A
- TECH $136.02
- Revenue Growth
- EQX 74.31
- TECH 5.23
- 52 Week Low
- EQX $4.95
- TECH $46.01
- 52 Week High
- EQX $12.93
- TECH $80.80
- Technical
- Relative Strength Index (RSI)
- EQX 49.56
- TECH 55.97
- Support Level
- EQX $10.24
- TECH $58.15
- Resistance Level
- EQX $11.31
- TECH $66.96
- Average True Range (ATR)
- EQX 0.44
- TECH 1.96
- MACD
- EQX -0.19
- TECH -0.34
- Stochastic Oscillator
- EQX 27.14
- TECH 50.17
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.